Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Robson

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of the antiangiogenic potential of AQ4NMartin O'Rourke, Claire Ward, Jenny Worthington, et al.
Cancers|December 23, 2022
Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual ConferenceSean P Kennedy, Oliver Treacy, Emma H Allott, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous CarcinomaTara Byrne, Laura Nelson, James P Beirne, et al.
Bioscience Reports|February 14, 2013
The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylationAhlam A Ali, Jonathan A Coulter, Claire H Ogle, et al.
The Journal of Gene Medicine|February 16, 2005
A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4NVerna McErlane, Anita Yakkundi, Helen O McCarthy, et al.
Nanomedicine (London, England)|October 1, 2015
RALA-mediated delivery of FKBPL nucleic acid therapeuticsRachel Bennett, Anita Yakkundi, Hayley D McKeen, et al.
International Journal of Pharmaceutics|January 24, 2016
Development of TMTP-1 targeted designer biopolymers for gene delivery to prostate cancerJohn W McBride, Ashley S Massey, J McCaffrey, et al.
Cancers|May 14, 2025
Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research's 60th AnniversarySeodhna M Lynch, Cathy E Richards, Aisling Ui Mhaonaigh, et al.
International Journal of Pharmaceutics|January 28, 2021
Rational design and characterisation of an amphipathic cell penetrating peptide for non-viral gene deliveryEmma M McErlean, Cian M McCrudden, John W McBride, et al.
Scientific Reports|December 11, 2020
FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular diseaseAndrzej S Januszewski, Chris J Watson, Vikki O'Neill, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of the antiangiogenic potential of AQ4NMartin O'Rourke, Claire Ward, Jenny Worthington, et al.
Cancers|December 23, 2022
Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual ConferenceSean P Kennedy, Oliver Treacy, Emma H Allott, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous CarcinomaTara Byrne, Laura Nelson, James P Beirne, et al.
Bioscience Reports|February 14, 2013
The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylationAhlam A Ali, Jonathan A Coulter, Claire H Ogle, et al.
The Journal of Gene Medicine|February 16, 2005
A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4NVerna McErlane, Anita Yakkundi, Helen O McCarthy, et al.
Nanomedicine (London, England)|October 1, 2015
RALA-mediated delivery of FKBPL nucleic acid therapeuticsRachel Bennett, Anita Yakkundi, Hayley D McKeen, et al.
International Journal of Pharmaceutics|January 24, 2016
Development of TMTP-1 targeted designer biopolymers for gene delivery to prostate cancerJohn W McBride, Ashley S Massey, J McCaffrey, et al.
Cancers|May 14, 2025
Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research's 60th AnniversarySeodhna M Lynch, Cathy E Richards, Aisling Ui Mhaonaigh, et al.
International Journal of Pharmaceutics|January 28, 2021
Rational design and characterisation of an amphipathic cell penetrating peptide for non-viral gene deliveryEmma M McErlean, Cian M McCrudden, John W McBride, et al.
Scientific Reports|December 11, 2020
FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular diseaseAndrzej S Januszewski, Chris J Watson, Vikki O'Neill, et al.
Pageof 8